Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης [ Τίτλος(Asc)] Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Tzouvelekis, A., Koliakos G., Ntolios P., Baira I., Bouros E., Oikonomou A., et al. (2011).  Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal.. J Transl Med. 9, 182.
Siska, E. K., Koliakos G., & Petrakis S. (2015).  Stem cell models of polyglutamine diseases and their use in cell-based therapies.. Front Neurosci. 9, 247.
Gavriilidis, G. I., Ntoufa S., Papakonstantinou N., Kotta K., Koletsa T., Chartomatsidou E., et al. (2020).  Stem cell factor Is implicated In microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemia.. Haematologica.
Apalla, Z., Lallas A., Sotiriou E., Lazaridou E., Vakirlis E., & Ioannides D. (2017).  Stellate erosion: the dermoscopic Nikolsky sign?. Eur J Dermatol. 27(6), 659-660.
Papavramidou, N., Nasta M., & Karpouzis A. (2010).  Steatoma through the early medical history.. Arch Dermatol. 146(4), 417.
Spyridi, S., Sokolaki S., Nimatoudis J., Iacovides A., & Kaprinis G. (2009).  Status epilepticus in a patient treated with olanzapine and mirtazapine.. Int J Clin Pharmacol Ther. 47(2), 120-3.
Kotoula, V., Lambaki S., Televantou D., Kalogera-Fountzila A., Nikolaou A., Markou K., et al. (2011).  STAT-Related Profiles Are Associated with Patient Response to Targeted Treatments in Locally Advanced SCCHN.. Transl Oncol. 4(1), 47-58.
Paraskevopoulos, E., Chalas N., Kartsidis P., Wollbrink A., & Bamidis P. (2018).  Statistical learning of multisensory regularities is enhanced in musicians: An MEG study.. Neuroimage. 175, 150-160.
Koskinas, K. C., & Giannoglou G. D. (2012).  Statins, plaque regression, and arterial remodeling: systemic drug effect, local effect, or a combination thereof?. Am J Cardiol. 110(2), 318.
Athyros, V. G., Kakafika A. I., Tziomalos K., Papageorgiou A. A., & Karagiannis A. (2008).  Statins for the prevention of first or recurrent stroke.. Curr Vasc Pharmacol. 6(2), 124-33.
Paraskevas, K. I., Athyros V. G., Briana D. D., Kakafika A. I., Karagiannis A., & Mikhailidis D. P. (2007).  Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures.. Curr Drug Targets. 8(8), 942-51.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2015).  Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?. Expert Opin Pharmacother. 16(10), 1449-61.
Tsartsalis, A. N., Dokos C., Kaiafa G. D., Tsartsalis D. N., Kattamis A., Hatzitolios A. I., et al. (2012).  Statins, bone formation and osteoporosis: hope or hype?. Hormones (Athens). 11(2), 126-39.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2016).  Statins and Type 2 Diabetes Mellitus: An Update After 1 Year.. Curr Pharm Des. 22(18), 2723-5.
Athyros, V. G., Karagiannis A., Kakafika A., Elisaf M., & Mikhailidis D. P. (2007).  Statins and renal function. Is the compound and dose making a difference?. Nephrol Dial Transplant. 22(3), 963-4; author reply 964.
Athyros, V. G., Kakafika A., Karagiannis A., & Mikhailidis D. P. (2007).  Statins and regression of coronary atherosclerosis.. JAMA. 297(20), 2197; author reply 2197.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2016).  Statins and non-alcoholic steatohepatitis.. J Hepatol. 64(1), 241-2.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2013).  Statins and nonalcoholic fatty liver disease: a bright future?. Expert Opin Investig Drugs. 22(9), 1089-93.
Athyros, V. G., Karagiannis A., & Mikhailidis D. P. (2010).  Statins and heart failure.. J Am Coll Cardiol. 55(15), 1644-5; author reply 1646.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2009).  Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention.. Curr Vasc Pharmacol. 7(3), 264-6.
Athyros, V. G., Kakafika A. I., Papageorgiou A. A., Pagourelias E. D., Savvatianos S. D., Elisaf M., et al. (2007).  Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients.. Open Cardiovasc Med J. 1, 8-14.
Athyros, V. G., & Wierzbicki A. S. (2014).  Statin-fibrate combination therapy is safe and effective in normalizing lipid profile and in keeping cardiovascular event rates low.. Curr Med Res Opin. 30(1), 57-8.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  Statin-fibrate combination for mixed dyslipidaemia: a limited option?. Curr Med Res Opin. 26(9), 2137-40.
Athyros, V. G., Karagiannis A., Liberopoulos E. N., Elisaf M., & Mikhailidis D. P. (2007).  Statin treatment may be beneficial to both the kidneys and the heart.. Perit Dial Int. 27(2), 215-6.
Kokkinos, P., Faselis C., Myers J., Kokkinos J. Peter, Doumas M., Pittaras A., et al. (2014).  Statin therapy, fitness, and mortality risk in middle-aged hypertensive male veterans.. Am J Hypertens. 27(3), 422-30.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές